Background: The rapid rise in Type 2 diabetes mellitus (T2DM) among young adults makes it important to understand structural changes in the brain at a presenile stage. This study examined global and regional brain atrophy in middle-aged adults with T2DM, with a focus on those without clinical evidence of microvascular complications. Methods: The study recruited 66 dementia-free middle-aged subjects (40 with T2DM, 26 healthy volunteers [HVs]). Patients were grouped according to the presence (T2DM-C; n = 20) or absence (T2DM-NC; n = 20) of diabetic microvascular complications. Global brain volume (including gray matter [GM] and white matter) was calculated based on voxel-based morphometry analysis. Regional GM volumes were further extracted using the anatomical automatic labeling template. Results: There was a significant difference in global brain volume among groups (P = 0.003, ANOVA). Global brain volume was lower in T2DM-C patients than in both T2DM-NC patients and HVs (mean [AESD] 0.720 AE 0.024 vs 0.736 AE 0.021 and 0.743 AE 0.019, respectively; P = 0.032 and P = 0.001, respectively). Regional analysis showed significant GM atrophy in the right Rolandic operculum (t = 3.42, P = 0.001) and right superior temporal gyrus (t = 2.803, P = 0.007) in T2DM-NC patients compared with ageand sex-matched HVs. Conclusions: Brain atrophy is present in dementia-free middle-aged adults with T2DM. Regional brain atrophy appears to be developing even in those with no clinical evidence of microvascular disturbances. The brain seems to be particularly vulnerable to metabolic disorders prior to peripheral microvascular pathologies associated with other target organs.
Introduction
In China, a booming economy has and continues to strongly boost the population's living standards. However, it is also associated with a marked increase in the prevalence of Type 2 diabetes mellitus (T2DM). 1 This rapid rise in T2DM, especially in those with a young age of onset and long disease duration, places China's diabetes patients at high risk of a plethora of diabetes-related complications. 2 Recently, the brain has been thought as a target organ for diabetic microvascular complications. 3 Although it is difficult to directly visualize small cerebrovascular structures in vivo, they can be observed indirectly using current magnetic resonance imaging (MRI) technology via effects on the parenchyma associated with abnormal vasculature. Brain atrophy is an MRI feature that is typically linked to cerebral small vessel diseases. 4 Although atrophic processes occur with normal aging, metabolic disorders, such as hyperglycemia, can accelerate the speed of atrophy and change the trajectory of the typical brain aging process.
Numerous studies, 5, 6 including the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) study, 7 have demonstrated a relationship between T2DM and brain atrophy in elderly subjects. Recently, the ACCORD trial further indicated that patients with peripheral microvascular complications are at high risk for future brain structural changes and cognitive decline. 8 However, very few studies have been conducted in middle-aged adults with T2DM, especially in those who do not show clinical evidence of peripheral microvascular disturbance. Given the prevalence of young T2DM in China, this may result in an increase in the prevalence of diabetes-related cognitive dysfunction in working-aged adults and lead to a substantial burden on society. Thus, efforts to elucidate the structural changes in the brain in working-aged subjects with T2DM have become essential and urgent.
In the present study, dementia-free middle-aged T2DM subjects were grouped based on the presence or absence of peripheral microvascular complications (T2DM-C and T2DM-NC, respectively). Voxel-based morphometric (VBM) analysis was performed on highresolution MRI datasets to detect whether early global brain atrophy had developed in subjects with T2DM compared with non-diabetic healthy volunteers (HVs). Moreover, the regional gray matter (GM) distribution was further investigated in these three groups.
Methods

Study participants
The present study was a cross-sectional observational study. Patients with T2DM admitted to the Shanghai General Hospital inpatient service between October 2016 and June 2017 were screened for eligibility to participate in the study. Patients were recruited who had a diagnosis of T2DM and were between 18 and 60 years of age. Patients meeting the following criteria were excluded: clinical evidence of a central nervous system disorder (e.g., cerebrovascular disease), history of previous clinically significant cardiovascular disease (e.g., myocardial infarction, angina), history of alcohol consumption >20 g/day, any history of psychiatric disorders, and any MRI contraindications. Participants underwent a cognitive test using the widely used MiniMental State Examination (MMSE). 9 Subjects who got full marks (30 points) on the MMSE were regarded as dementia free and were recruited to the study. In addition, age-and sex-matched, right-handed, non-diabetic HVs were recruited to the study. All subjects provided written informed consent before taking part in the study, and the study was approved by the Shanghai General Hospital Ethics Committee.
Assessment of microvascular complications
Retinal fundus photographs were taken in all patients with diabetes. Diabetic retinopathy was defined as present if any of the following lesions were detected: retinal microaneurysms, hemorrhages, hard exudates, soft exudates, neovascularization, or evidence (also history) of laser photocoagulation. The urinary albumin-tocreatinine ratio (UACR) was measured in first-void clean-catch urine samples. Microalbuminuria was defined as UACR >30 μg/mg on two consecutive days. The presence of diabetic peripheral neuropathy (DPN) was defined using the Toronto Consensus statement, 10 with patients meeting any two of the following criteria regarded as having DPN: (i) presence of typical neuropathic sensory symptoms; (ii) a symmetric decrease in distal sensation or loss of ankle reflexes; and (iii) abnormal nerve conduction studies.
Patients with at least one of the diabetes-related microvascular complications (retinopathy, nephropathy, DPN) allocated to the T2DM-C group. Patients without any detectable clinical evidence of retinopathy, nephropathy, and peripheral neuropathy were allocated to the T2DM-NC group.
Acquisition of magnetic resonance images
High-resolution, three-dimensional (3D) T 1 -weighted MRI scans were acquired using a magnetization-prepared rapid-gradient echo sequence at 3 Tesla (Ingenia; Philips Healthcare, Best, Netherlands). The scanning parameters were as follows: flip angle 7
, echo time (TE) 3. 
Preprocessing of MRI data
The T 1 -weighted images were preprocessed using statistical parametric mapping (SPM8; http://www.fil.ion.ucl. ac.uk/spm/software/spm8/, accessed 18 August 2017) implemented in Matlab (R2014a; https://in.mathworks. com/products/matlab.html, accessed 18 August 2017). In order to assess the volume of different tissue types, T 1 -weighted images were segmented into GM and white matter (WM) using the VBM8 toolbox (http://www. neuro.uni-jena.de/vbm/download/, accessed 18 August 2017). These images were preprocessed through a standard pipeline. 11 Specifically, the 3D structural database of each subject was first spatially registered on the Montreal Neurological Institute (MNI) atlas space. Normalized images were then segmented into GM and WM. Different tissue images were scaled using nonlinear components to correct for gross individual brain size effects during spatial normalization. Finally, the resulting images were smoothed by convolving with an isotropic Gaussian kernel (full-width-at-half-maximum [FWHM] 8 mm).
Statistical analysis
Quantitative data, namely age, body mass index (BMI), HbA1c, uric acid, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total brain volume, GM volume, and WM volume were tested for normality and are expressed as the group mean AE SD. The significance of differences among mean values of the three groups (i.e., T2DM-C, T2DM-NC, and HVs) was evaluated using one-way analysis of variance (ANOVA). Where a statistically significant difference was found, post hoc comparisons between each pair of two groups were performed using Student's t-tests.
Quantitative continuous data that were not normally distributed (duration of diabetes and triglyceride concentrations) are expressed as the median (minimum, maximum). The significance of differences in data that were not normally distributed among the three groups was evaluated using Kruskal-Wallis non-parametric comparisons. Mann-Whitney U-tests were used for post hoc comparisons of data that were not normally distributed.
Grouped non-continuous data, such as sex, presence of hypertension, presence of retinopathy, presence of microalbuminuria, presence of DPN, and use of statins, were compared using Chi-squared tests. In order to compare brain atrophy among the three groups, total brain volume was calculated by summing the volume of the GM and WM for each subject. The relationship between total brain volume and metabolic indices was analyzed using Spearman correlation coefficients.
Statistical analyses were performed using SPSS 19 (IBM Corp., Armonk, NY, USA). Two-sided P < 0.05 was considered significant.
Statistical analysis of functional imaging data
The brain regional GM volumes were extracted using the anatomical automatic labeling (AAL) template 12 (Neurodegenerative Diseases Institute, UMR 5293, Team 5, CEA, CNRS, Université de Bordeaux) while restricting voxels with tissue class probability >0.15 to assess regional differences among groups. Specifically, for a region of interest (ROI) in the AAL template, GM volume was calculated as the average of the GM volume index of each voxel within the ROI from the smoothed modulated GM image. It should be noted that the likely confounding effects of age and gender variables were regressed out before group comparisons were made using a general linear model. The ANOVA level of significance for regional GM among the three groups was set at P < 0.01 (permutation-based nonparametric testing corrected). For post hoc analysis, the level of significance was set at P < 0.017 (Bonferroni corrected).
Results
Demographic and clinical characteristics
Sixty-six subjects (20 T2DM-NC, 20 T2DM-C, and 26 HVs) were recruited to the present study. Their mean age was 43 AE 9.7 years. In the T2DM-C group, 13 patients had diabetic retinopathy, six had microalbuminuria and 17 patients had DPN. The demographic and clinical details of the three groups are given in Table 1 . Subjects were well matched for age (P = 0.13), sex distribution (P = 0.203), and duration of diabetes (P = 0.127). There were significant differences among the three groups in triglyceride levels (P = 0.013), HDL-C levels (P < 0.001), the prevalence of hypertension (P = 0.002), and the use of statins (P = 0.030). Post hoc analysis showed that, compared with HVs, T2DM subjects had higher mean triglyceride levels (T2DM-NC vs HVs, P = 0.001; T2DM-C vs HV, P = 0.011) and lower mean HDL-C levels (T2DM-NC vs HVs, P < 0.001; T2DM-C vs HV, P < 0.001), a higher prevalence of hypertension (T2DM-NC vs HVs, P = 0.008; T2DM-C vs HV, P < 0.001), and higher statin usage (T2DM-NC vs HVs, P = 0.017; T2DM-C vs HV, P = 0.007). However, post hoc analysis did not indicate significant differences between the T2DM-NC and T2DM-C groups in any demographic or clinical characteristics.
Global brain volume
There was a significant difference in the mean GM volumes among the HVs, T2DM-NC, and T2DM-C groups (0.640 AE 0.021, 0.631 AE 0.021, and 0.618 AE 0.027, respectively; P = 0.006). Post hoc analysis showed that the mean GM volume was significantly lower in the T2DM-C compared with HVs group (P = 0.003). There was no significant difference in WM volumes among the HVs, T2DM-NC, and T2DM-C groups (0.914 AE 0.041, 0.912 AE 0.047, and 0.890 AE 0.046, respectively; P = 0.156).
After summing the GM and WM volumes for each subject, there seemed to be a more obvious difference in total brain volume among the study groups (ANOVA, P = 0.003; Fig. 1 ). Post hoc analysis indicated brain volume was lower in T2DM-C subjects than in T2DM-NC and HV subjects (0.720 AE 0.024, 0.736 AE 0.021 and 0.743 AE 0.019, respectively; P = 0.032 and P = 0.001 vs T2DM-C, respectively). However, there was no significant difference in total brain volume between subjects in the T2DM-NC and HV groups (P = 0.264).
There was a significant negative correlation between total brain volume and duration of diabetes (ρ = −0.355, P = 0.003), BMI (ρ = −0.335, P = 0.006), and the grade of hypertension (ρ = −0.384, P = 0.001). In addition, HbA1c was inversely related to total brain volume, although this was not statistically significant (ρ = −0.251, P = 0.051). There was no significant correlation between blood lipids (total cholesterol, triglyceride, HDL-C, and LDL-C) and brain volume. However, there was a significant positive association between the use of statins and total brain volume (ρ = 0.363, P = 0.003).
Regional GM volumes in the three study groups Figure 2 shows the results of ANOVA of regional GM volumes among the three study groups: P < 0.01 was considered to be statistically significant. Differences were found primarily in the right hemisphere, in six cerebral regions: right inferior frontal gyrus (F = 8.048, P = 0.001), right Rolandic operculum (F = 5.563, P = 0.006), right hippocampus (F = 7.715, P = 0.001), Data are presented as n (%), mean AE SD, or median (minimum, maximum) as appropriate. *P < 0.05 compared with healthy volunteers (HVs). Post hoc comparisons were made using Student's t-test for continuous variables with a normal distribution, Mann-Whitney U-tests for continuous variables without a normal distribution, and Chi-squared tests for non-continuous data. T2DM-NC, Type 2 diabetes mellitus (T2DM) subjects with no complications (i.e., without any detectable clinical evidence of retinopathy, nephropathy, and peripheral neuropathy); T2DM-C, T2DM subjects with complications (i.e., with at least one of the diabetes-related microvascular complications of retinopathy, nephropathy, and diabetic peripheral neuropathy); BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides. *P-values were determined by analysis of variance (AVNOVA) for continuous variables with a normal distribution, Kruskal-Wallis tests for continuous variables without a normal distribution, and Chi-squared tests for non-continuous data.
right amygdala (F = 6.817, P = 0.002), right caudate (F = 6.832, P = 0.002), and right superior temporal gyrus (F = 5.649, P = 0.006). Post hoc analysis of the above six cerebral regions is shown in Fig. 3 . In addition to the significant differences between the T2DM-C and HV groups in all the six cerebral regions, there were significant differences in the inferior frontal gyrus (t = 2.227, P = 0.032), hippocampus (t = 2.517, P = 0.016), amygdala (t = 2.295, P = 0.027), and caudate (t = 3.628, P = 0.001) between the T2DM-C and T2DM-NC groups. Further, although there were no significant differences between the T2DM-NC and HV groups in global brain volumes (including GM, WM, and total brain volume), regional GM volumes showed significant differences in the right Rolandic operculum (t = 3.42, P = 0.001) and right superior temporal gyrus (t = 2.803, P = 0.007).
Discussion
Type 2 diabetes mellitus has become a worldwide pandemic. Driven by economic development and the consequent sedentary lifestyle, the prevalence of T2DM in China has increased rapidly in recent decades, with a disproportionate burden among young adults. 13 Earlier diagnosis results in longer disease duration and longterm suboptimal metabolic control may lead to an impending epidemic of diabetic complications in working-age adults.
14 Diabetes-related complications in the working population are not only a public health problem, but also affect several societal issues.
Brain atrophy is a neuroimaging feature that is commonly observed in the elderly. 4 It may present with diffuse neurological symptoms of progressive cognitive decline, gait disturbance, and dementia. The underlying pathological changes of atrophy are heterogeneous and probably initiated by disturbance of the blood-brain barrier. 15 Risk factors, such as hyperglycemia, which can cause further insults to the integrity of the bloodbrain barrier, have been suggested to accelerate brain atrophy. 5 Numerous studies have addressed the relationship between T2DM and brain atrophy in elderly adults. An early multicenter cross-sectional study (including subjects with Type 1 diabetes mellitus [T1DM] and T2DM) revealed that diabetes was associated with cortical brain atrophy based on a subjective grading scale rated by neuroradiologists. 5 Modern MRI acquisition methods can yield 3D datasets with high spatial resolution that, when coupled with analytical methods such as VBM, provide more robust quantitative tissue volume assessment techniques capable of identifying if and where neuroanatomical changes occur. Using these techniques, it has been reported that T2DM is associated with a regional distribution of brain atrophy in older people. 6 A subsequent longitudinal study using baseline MRI from the ACCORD-MIND study further demonstrated intensive glycemic treatment decelerated brain volume loss. 7 Although brain atrophy is well recognized in diabetes, very few studies have been conducted in working-age adults with T2DM. In healthy young and middle-aged adults from the Framingham Heart Study third-generation cohort, lower brain GM volume and impaired attention and memory have been associated with both increased fasting blood glucose and the presence of diabetes (including both T1DM and T2DM). 16 A small sample study conducted in obese adolescents found subtle changes in brain structure in patients with T2DM. 17 Data collected in the present study from "dementia-free" middle-aged adults with T2DM demonstrate that changes in global brain volume, especially lower GM volume, are already present. Together, the findings from the present and previous studies indicate that brain atrophy may not be limited to a degenerative aging process. The data of the present study suggest that there is an atrophic pathological process that appears to augment the aging process at an earlier stage, manifesting itself in young T2DM subjects who have no significant signs of cognitive impairment.
Previous studies have provided links between microvascular complications and brain atrophy. 8, [18] [19] [20] The results of the present study show that global brain atrophy is dominant in subjects with T2DM and microvascular complications, supporting the hypothesis that the brain is an additional major target organ for microvascular complications of diabetes. 3 In further brain subregional analysis in the present study, significantly lower GM volumes were shown in various right hemispheric regions, suggesting hemispheric asymmetry. Cortical asymmetry has been reported in neurodegenerative disorders, such as Alzheimer's disease, in which GM loss begins in the left hemisphere. 21 The present study demonstrated that T2DM is associated with lower GM volumes in the temporal cortex (hippocampus, superior temporal gyrus), frontal cortex (inferior frontal gyrus, Rolandic operculum), and subcortical nuclei (amygdala, caudate). These affected brain regions are known to be closely related to cognitive and language-processing functions. These regions are similar to those identified in a previous study conducted in older subjects with T2DM, 6 which reported that GM atrophy appears to be distributed in the hippocampi, temporal, frontal, and cingulate cortices, and subcortical nuclei.
Further, the present study found that global brain volume did not differ significantly between the T2DM-NC and age-and sex-matched HVs following post hoc analysis. However, regional distribution analysis identified lower GM volumes in the right Rolandic operculum and right superior temporal gyrus in T2DM-NC subjects. These two brain regions, which are linked to language processing, seem to be more susceptible to Figure 3 Results of post hoc analysis of regional gray matter atrophy in healthy volunteers (HVs) and middle-aged Type 2 diabetes mellitus (T2DM) subjects with (T2DM-C) or without (T2DM-NC) diabetic microvascular complications. In particular, the gray matter volumes in the Rolandic operculum (t = 3.42, P = 0.001) and the superior temporal gyrus (t = 2.803, P = 0.007) were significantly lower in the T2DM-NC group compared with the HVs group. Data are the mean AE SD. *P < 0.05, **P < 0.01 (Bonferroni corrected). Frontal_Inf_Oper_R, right inferior frontal gyrus, opercular part; Rolandic_Oper_R, right Rolandic operculum; Hippocampus_R, right hippocampus; Amygdala_R, right amygdala; Caudate_R, right caudate; Temporal_Sup_R, right superior temporal gyrus. metabolic changes than peripheral microvascular target organs. These findings imply that structural changes to the brain are in progress even in dementia-free, middleaged T2DM subjects without any clinically detectable microvascular complications.
Such data are important particularly because the subjects in the present study were all of working age. Early neuropathogenesis may potentially affect daily life. Unlike annual microvascular disease screenings for DPN, diabetic foot, retinopathy, and nephropathy, investigations for potential diabetes-induced cognitive disorders are not routinely undertaken, especially in those who do not show obvious signs of cognitive impairment. The early identification of cognitive impairment in young diabetic patients may be necessary because of their longer life expectancy, the need for career planning, and pre-or early symptomatic treatment.
The results of the correlation analysis showed that total brain volume is significantly linked not only with the duration of diabetes, but also with known cardiovascular risk factors, such as increased BMI, hypertension, and dyslipidemia (as evidenced by the use of statins). These findings imply that, apart from glycemic control, brain atrophy may be associated with such cardiovascular risk factors. This is consistent with a former study that compared cerebral MRI between subjects with T1DM and those in T2DM and suggested that risk factors for atherosclerosis may be associated with cognitive disturbances and cortical atrophy in T2DM. 22 Such results indicate that T2DM subjects may be more prone to brain aging because of multiple metabolic disorders. In addition to metabolic risk factors, ambient air pollution may become strong factor that accelerates brain atrophy and reduces cognitive function in large cities of developing countries, such as Shanghai. 23 Several limitations of the present study must be considered. First, we did not perform more detailed cognitive assessments, so it is possible that potential cognitive changes, undetected using the current assessment strategy, are linked to subtle structural changes in the brain. However, we used the accepted more-stringent higher threshold of MMSE = 30 as n inclusion criterion for the present study. Another limitation of the study is the relatively small number of subjects in each group. A larger sample may be required to strengthen the evidence of global and regional structural changes in the brain in T2DM patents who do not show evidence of extracranial microvascular disorders.
Longitudinal research is needed to elucidate the clinical outcomes throughout the lives of middle-aged patients with T2DM who have subtle structural changes in the brain in the early stages of the disease course.
In conclusion, the findings of the present show that brain atrophy is present in dementia-free middle-aged adults with T2DM. Even in those without clinical evidence of microvascular complications (diabetic retinopathy, microalbuminuria, and DPN), the development of regional GM atrophy is already occurring. The brain seems to be vulnerable to metabolic disturbances, but additional larger and longitudinal studies are required to confirm this.
